Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CDXS | Common Stock | Options Exercise | $89.3K | +38.5K | +3.76% | $2.32 | 1.06M | Mar 9, 2022 | Direct | F1 |
transaction | CDXS | Common Stock | Sale | -$743K | -38.5K | -3.63% | $19.30* | 1.02M | Mar 9, 2022 | Direct | F1, F2 |
transaction | CDXS | Common Stock | Options Exercise | $89.3K | +38.5K | +3.76% | $2.32 | 1.06M | Mar 10, 2022 | Direct | F1 |
transaction | CDXS | Common Stock | Sale | -$729K | -38.5K | -3.63% | $18.93* | 1.02M | Mar 10, 2022 | Direct | F1, F3 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
transaction | CDXS | Stock Option (Right to Buy) | Options Exercise | $0 | -38.5K | -16.63% | $0.00 | 193K | Mar 9, 2022 | Common Stock | 38.5K | $2.32 | Direct | F1 |
transaction | CDXS | Stock Option (Right to Buy) | Options Exercise | $0 | -38.5K | -19.95% | $0.00 | 155K | Mar 10, 2022 | Common Stock | 38.5K | $2.32 | Direct | F1 |
Id | Content |
---|---|
F1 | Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 5, 2021. |
F2 | This transaction was executed in multiple trades in prices ranging from $18.71 to $19.65, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |
F3 | This transaction was executed in multiple trades in prices ranging from $18.69 to $19.26, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote. |